The impact of eTRF was investigated in a study first conducted by Jamshed H. et al. [51] and all metabolic parameters (fasting glucose, fasting insulin, lipid profile, oxidative stress, hypertension, and postprandial insulin) were improved even without fat mass reduction [50,51]. The gene discussed is INS; the disease is hypertensive disorder.